Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Capital Expenditures for 3 consecutive years, with $279000.0 as the latest value for Q2 2025.

  • Quarterly Capital Expenditures rose 71.17% to $279000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $279000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $279000.0 for FY2025, N/A changed from the prior year.
  • Capital Expenditures hit $279000.0 in Q2 2025 for Camp4 Therapeutics, up from -$178000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $279000.0 in Q2 2025 to a low of -$178000.0 in Q4 2024.
  • Historically, Capital Expenditures has averaged $104400.0 across 3 years, with a median of $163000.0 in 2024.
  • Biggest five-year swings in Capital Expenditures: plummeted 173.25% in 2024 and later surged 71.17% in 2025.
  • Year by year, Capital Expenditures stood at $243000.0 in 2023, then tumbled by 173.25% to -$178000.0 in 2024, then surged by 256.74% to $279000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CAMP at $279000.0 in Q2 2025, -$178000.0 in Q4 2024, and $163000.0 in Q2 2024.